The Effect of Maternal Peripartum Anti-TNFα Use on Infant Immune Response

Digestive Diseases and Sciences

Volumn 61, Issue 6, 2016, Pages 1622-1627

  Sheibani, Sarah ^a,f   Cohen, Russell ^b   Kane, Sunanda ^c   Dubinsky, Marla ^d   Church, Joseph A ^e   Mahadevan, Uma ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c MAYO CLINIC   (United States)

^d MOUNT SINAI MEDICAL CENTER   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Anti TNF ; Immune response; Inflammatory bowel disease; Pregnancy

Indexed keywords

ADALIMUMAB; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLIXIMAB; TETANUS TOXOID; BACTERIUM ANTIBODY; GASTROINTESTINAL AGENT; HAEMOPHILUS VACCINE; IMMUNOGLOBULIN; TUMOR NECROSIS FACTOR;

ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; FEMALE; GESTATIONAL AGE; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; INFANT; INFLAMMATORY BOWEL DISEASE; MAINTENANCE THERAPY; MALE; PERINATAL PERIOD; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; THIRD TRIMESTER PREGNANCY; ADULT; ANTAGONISTS AND INHIBITORS; BLOOD; FETOMATERNAL TRANSFUSION; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASES; NEWBORN; PREGNANCY; YOUNG ADULT;

ADALIMUMAB; ADULT; ANTIBODIES, BACTERIAL; FEMALE; GASTROINTESTINAL AGENTS; HAEMOPHILUS VACCINES; HUMANS; IMMUNOGLOBULINS; INFANT, NEWBORN; INFLAMMATORY BOWEL DISEASES; INFLIXIMAB; MATERNAL-FETAL EXCHANGE; PREGNANCY; PROSPECTIVE STUDIES; TETANUS TOXOID; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84952657613     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-015-3992-2     Document Type: Article

References (22)

1. Loftus E, Sandborn W. Epidemiology of inflammatory bowel disease. Gastroenterol Clin N Am. 2002;31:1–20.
2. Bush MC, Patel S, Lapinksi RH, et al. Perinatal outcomes in inflammatory bowel disease. J Matern Fetal Neonatal Med. 2004;15:237–241.
3. Norgard B, Hundborg HH, Jacobsen BA, et al. Disease activity in pregnant women with Crohn’s disease and birth outcomes: a regional Danish Cohort study. Am J Gastroenterol. 2007;102:1947–1954.
4. Reddy D, Murphy S, Kane S, et al. Relapse of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes. Am J Gastroenterol. 2008;103:1203–1209.
5. Katz JA, Antoni C, Keenan GF, et al. Outcomes of pregnancy in women receiving infliximab for the treatment of Crohn’s disease and rheumatoid arthritis. Am J Gastroenterol. 2004;99:2385–2392.
6. Mahadevan U, Cucchiara S, Hyams J, et al. The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn’s and Colitis Organization: pregnancy and pediatrics. Am J Gastroenterol. 2011;105:214–223.
7. Casanova MJ, Chaparro M, Domenech E, et al. Safety of thiopurines and anti-TNF drugs during pregnancy in patients with inflammatory bowel disease. Am J Gastroenterol. 2013;108:433–440.
8. Mahadevan U, Martin C, Sandler RS, et al. PIANO: a 1000 patient prospective registry of pregnancy of pregnancy outcomes in women with IBD exposed to immunomodulators and biologic therapy. Gastroenterol. 2012;142:S-149. (abstract).
9. Mahadevan U, Wolf D, Dubinsky M, et al. Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clin Gastro Hepatol. 2013;11:286–292.
10. Julsgaard M, Christensen L, Gibson P. Adalimumab and infliximab level in neonates. Gastroenterology. 2015;148:S-108. (abstract).
11. Pasparakis M, Alexopoulou L, Episkopou V. Immune and inflammatory responses in TNFα-deficient mice: a critical requirement for TNFoL in the formation of primary B cell follicles follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med. 1996;184:1397–1411.
12. Wen L, Shinton SA, Hardy RR, et al. Association of B-1 B cells with follicular dendritic cells in spleen. J Immunol. 2005;174:6918–6926.
13. Mamula P, Markowitz J, Piccoli D. Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease. Clin Gastro Hepatol. 2007;5:851–856.
14. Fiorino G, Peyrin-Biroulet L, Naccarato P, et al. Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study. Inflamm Bowel Dis. 2012;18:1042–1047.
15. Yeh S, Ward J, Partridge S. Safety and Immunogenicity of a pentavalent diphtheria, tetanus, pertussis, hepatitis B and polio combination vaccine in infants. Pediatr Infect Dis J. 2001;20:973–980.
16. Kane S, Acquah L. Placental transport of immunoglobulins: a clinical review for gastroenterologist who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy. Am J Gastroenterol. 2009;104:228–233.
17. Vasiliauskas EA, Church JA, Silverman N, et al. Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol. 2006;4:1255–1258.
18. Zelinkova Z, de Haar C, de Ridder L, et al. High intra-uterine exposure to infliximab following maternal anti-TNF treatments during pregnancy. Aliment Pharmacol Ther. 2011;33:1053–1058.
19. Nesbitt A, Brown D, Stephens S. Placental transfer and accumulation in milk of the anti-TNF antibody TN3 in rats: immunoglobulin G1 verus PEGylated Fab. Am J Gastroenterol. 2006;101:S420–S470. (abstract).
20. Martin PL, Oneda S, Treacy G. Effects of an anti-TNF-alpha monoclonal antibody, administered throughout pregnancy and lactation, on the development of the macaque immune system. Am J Reprod Immunol. 2007;58:138–149.
21. Bortlik M, Duricova D, Machikova N, et al. Impact of anti-tumor necrosis factor alpha antibodies administered to pregnant women with inflammatory bowel disease on long-term outcome of exposed children. Inflamm Bowel Dis. 2014;20:495–501.
22. Cheent K, Nolan J, Shariq S, et al. Case report: fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn’s disease. J Crohns Colitis. 2010;4:603–605.